At the Bedside
Does improving access for patients equal loss of critical quality oversight?
Accurately identifying those with tuberculosis infection and disease is crucial in initiative to reduce related deaths.
To keep up with higher sample volume despite a smaller staff, labs must learn to do more with less.
Following the Yellow Brick Road
Exploring the advances moving us forward in digital pathology
NGS for Drug Resistance
Today’s tools are transforming the impact of molecular data on patient and population health.
The Molecular Edge
Epigenetics & Cancer Treatment
[button link=”http://advanceweb.com/SharedResources/EBook/2016/December/AL122616/index.html” size=”medium” target=”new” color=”default”]Read This Issue Now![/button]